This webinar is intended to provide blood establishments and other stakeholders with an overview of OBRR’s approach to the review of biologics license applications for the manufacture of blood and blood components, including source plasma. In this event, OBRR staff will give presentations on select topics and address questions submitted by registra
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/AjQcvT5
No comments:
Post a Comment